1. Home
  2. HNVR vs SPRO Comparison

HNVR vs SPRO Comparison

Compare HNVR & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

HOLD

Current Price

$21.70

Market Cap

153.5M

Sector

Finance

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.47

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
SPRO
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
124.5M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
HNVR
SPRO
Price
$21.70
$2.47
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$24.50
N/A
AVG Volume (30 Days)
4.7K
277.5K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
111.81
EPS
1.00
0.15
Revenue
N/A
$66,802,000.00
Revenue This Year
$35.49
N/A
Revenue Next Year
$8.61
N/A
P/E Ratio
$21.59
$15.60
Revenue Growth
N/A
39.24
52 Week Low
$18.31
$0.51
52 Week High
$24.36
$3.09

Technical Indicators

Market Signals
Indicator
HNVR
SPRO
Relative Strength Index (RSI) 53.50 55.67
Support Level $21.60 $2.15
Resistance Level $22.41 $2.70
Average True Range (ATR) 0.50 0.13
MACD 0.13 -0.01
Stochastic Oscillator 49.24 51.20

Price Performance

Historical Comparison
HNVR
SPRO

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: